SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics ... alterations that may limit their usefulness for stem cell therapy. The study authors found that approximately 15% of CRISPR ...

Topics span the application of optical genome mapping (OGM) in research applications in cancer, cell and gene therapy, and genetic diseases SAN DIEGO, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Bionano ...

president and chief executive officer of Bionano. To learn more about OGM’s utility in cell and gene therapy applications, please visit this website. The publication from García-García et al.

Erik Holmlin, president and chief executive officer of Bionano, commented ... like blood cancer are insufficient to reliably guide therapy selection and patient management, due to their ...

SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics ... and manufacturing applications in stem cell therapy. ISSCR’s annual meeting brings together industry, medical, and academic ...

for analysis of CRISPR/Cas edited cells for use in CAR-T therapy SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that the American Society of ...

and Dr. Alicia Bertolotti from Bionano presenting on the utility of optical genome mapping (OGM) across cell and gene therapy research, development and manufacturing applications Two scientific ...

and Dr. Alicia Bertolotti from Bionano presenting on the utility of optical genome mapping (OGM) across cell and gene therapy research, development and manufacturing applications Two scientific ...